Timothy Rolph - Chief Scientific Officer at Akero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
AKRO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Timothy Rolph - trading volume in the past year for Akero Therapeutics, Inc.

Holdings reported by Timothy Rolph for Akero Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 198K $6.17M $31.10 Dec 16, 2024 Direct
Stock Option (Right to Buy) 60K Dec 16, 2024 Direct Common Stock

Transactions reported by Timothy Rolph for Akero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.